next one coming












Novartis layoffs in IT have been low this year - could be because they will be bundled out of NBS IT resources that are currently supporting Alcon - when Alcon is divested in 18 months:low value-add roles like "global head of IGM" etc) need to be axed quickly
 


Novartis layoffs in IT have been low this year - could be because they will be bundled out of NBS IT resources that are currently supporting Alcon - when Alcon is divested in 18 months:low value-add roles like "global head of IGM" etc) need to be axed quickly

All of the NBS IT folks supporting Alcon will be let go; only those IT folks embedded within Alcon in Business IT roles will survive the divestiture - until ALcon's new owner will evaluate their cost-benefit. Tough years ahead for these employees.
 




All of the NBS IT folks supporting Alcon will be let go; only those IT folks embedded within Alcon in Business IT roles will survive the divestiture - until ALcon's new owner will evaluate their cost-benefit. Tough years ahead for these employees.

Someone has a very big bonus dependent on the layoffs.
 






IRIS is the biggest waste of money in Alcon. Need to clean house in this team of egotistical idiots starting with TP.

Alcon will go through a Novartis IT Exit or NEXIT (a la Brexit): not only Novartis IT people, but also ineffective Novartis IT ideas like IRIS will be ripped off like a band-aid; so IRIS teams will be axed hard and fast.

After the dust settles, Alcon IT will wind up a better function in 1-2 years post Novartis ... the tough pill to swallow is that some good Alcon IT people will also be axed in the process - Novartis management calls that collateral damage
 




2019 hit is expected to be (for the first time ever) in HQ (Basel) - shared functions (NBS IT, Quality, HR, PK, exec ranks) expected to be moved to lower cost geographies (with lower benefits) - Easter Europe (Prague) and India mostly. Key driver is to shore up falling margins fast. CH is just too pricey for a home base and cushy packages, unfortunately.
 


Basel employees are fighting to survive via lobbying at CH political level - the Novartis ownership family supported this in the past, but with falling margins, they have no choice but to cut at HQ. WIth a global recession looming in 2019, this will be especially tough for US expats who settled in CH for NOvartis jobs ...
 


Had to happen sometime - too many overpaid, complacent, under-performing NOvartis lifers in Basel - they will, however, collect a fat severance on the way out, with heavy pensions for those who survived long enough ... so, some cushion for that hard landing.
 


Had to happen sometime - too many overpaid, complacent, under-performing NOvartis lifers in Basel - they will, however, collect a fat severance on the way out, with heavy pensions for those who survived long enough ... so, some cushion for that hard landing.

Does Not make it any easier - not that many jobs that pay for minimal productivity in Basel area pharma cos ... hopefully the fat pigs saved enough to retire and didn't fritter away he big bucks on luxuries, thinking the gravy train would go on till they are in their sixties
 


Basel employees are fighting to survive via lobbying at CH political level - the Novartis ownership family supported this in the past, but with falling margins, they have no choice but to cut at HQ. WIth a global recession looming in 2019, this will be especially tough for US expats who settled in CH for NOvartis jobs ...

2019 Q3 and Q4 will be bumpy; Q3 early earnings release will lose all Alcon profits (spin off on 4/9). Axes will be out for cost-reduction
 


Some Basel survivors have been given until Q3 2020 end to find other jobs or relocate at lower pay to Prague or India; better than those that have only until early Q3 2019 to leave. A tough time to be sure, but was inevitable. Vas has to find immediate cost reductions somewhere to meet his target margins, and IT provides easy pickins ...
 


Some Basel survivors have been given until Q3 2020 end to find other jobs or relocate at lower pay to Prague or India; better than those that have only until early Q3 2019 to leave. A tough time to be sure, but was inevitable. Vas has to find immediate cost reductions somewhere to meet his target margins, and IT provides easy pickins ...

Going from shit to shiter. No big loss, what could go wrong. Expecting an even better experience when the centres of excellence are fully off shored.
 



Write your reply...